Fresh Recalls

FDAClass I · Drug · Recall D-0773-2026 · Recalled August 19, 2026

Optiray Imaging Bulk Package-350 recall — Liebel-Flarsheim Company LLC

Agency report date: August 19, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Optiray Imaging Bulk Package-350
Company / brand
Liebel-Flarsheim Company
Lot / serial / date codes
Lot # 25ZF3670, Exp Date: May 31, 2027.
Distribution
Distributed Nationwide in the US and Mexico.
Agency product description and boundaries

Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class I: most serious — reasonable probability of serious health consequences or death.

Affected product: Optiray Imaging Bulk Package-350

3. Open the official notice or contact

Official recall ID
D-0773-2026
Brand
Liebel-Flarsheim Company
Classification
Class I
Units affected
3,486 500mL-vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Raleigh, NC, United States
Firm address
8800 Durant Rd, 27616-3104

Identifying details (verbatim from the notice)

Product codes / lots
Lot # 25ZF3670, Exp Date: May 31, 2027.
Distribution
Distributed Nationwide in the US and Mexico.
Firm notified the public via
E-Mail
FDA event ID
99510
Recall initiated
July 31, 2026
FDA classified
August 19, 2026
FDA report date
August 19, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page